These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6491917)

  • 1. Systematic error associated with apparatus 2 of the USP dissolution test V: Interaction of two tableted prednisone formulations with glass and plastic vessels.
    Cox DC; Furman WB
    J Pharm Sci; 1984 Aug; 73(8):1125-7. PubMed ID: 6491917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere.
    Cox DC; Wells CE; Furman WB; Savage TS; King AC
    J Pharm Sci; 1982 Apr; 71(4):395-9. PubMed ID: 7086644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
    Cox DC; Furman WB
    J Pharm Sci; 1984 May; 73(5):670-6. PubMed ID: 6737242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
    Zhang Y; Bredael G; Armenante PM
    J Pharm Sci; 2013 Aug; 102(8):2718-29. PubMed ID: 23861178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic error associated with apparatus 2 of the USP dissolution test III: limitations of calibrators and the USP suitability test.
    Cox DC; Furman WB; Thornton LK; Moore TW; Jefferson EH
    J Pharm Sci; 1983 Aug; 72(8):910-3. PubMed ID: 6620145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated sampling of in vitro dissolution medium: effect of sampling probes on dissolution rate of prednisone tablets.
    Savage TS; Wells CE
    J Pharm Sci; 1982 Jun; 71(6):670-3. PubMed ID: 7097531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic error associated with apparatus 2 of the USP dissolution test I: Effects of physical alignment of the dissolution apparatus.
    Cox DC; Furman WB
    J Pharm Sci; 1982 Apr; 71(4):451-2. PubMed ID: 7086657
    [No Abstract]   [Full Text] [Related]  

  • 8. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
    Qureshi SA; McGilveray IJ
    Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium.
    Cox DC; Furman WB; Page DP
    J Pharm Sci; 1983 Sep; 72(9):1061-4. PubMed ID: 6631694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A better dissolution method for ranitidine tablets USP.
    Cappola ML
    Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cause of high variability in drug dissolution testing and its impact on setting tolerances.
    Qureshi SA; Shabnam J
    Eur J Pharm Sci; 2001 Jan; 12(3):271-6. PubMed ID: 11113646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing.
    Bai G; Armenante PM
    J Pharm Sci; 2009 Apr; 98(4):1511-31. PubMed ID: 18781589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vibration effects of lab equipment on dissolution testing with USP paddle method.
    Gao Z; Thies A; Doub W
    J Pharm Sci; 2010 Jan; 99(1):403-12. PubMed ID: 19544371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The USP Performance Verification Test, Part II: collaborative study of USP's Lot P Prednisone Tablets.
    Glasgow M; Dressman S; Brown W; Foster T; Schuber S; Manning RG; Wahab SZ; Williams RL; Hauck WW
    Pharm Res; 2008 May; 25(5):1110-5. PubMed ID: 18172582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADS-12: an automated programmable 12-tablet dissolution testing system.
    Cioffi FJ; Martynovych S; Bendrot H
    J Pharm Sci; 1979 Oct; 68(10):1280-6. PubMed ID: 512861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrodynamic investigation of USP dissolution test apparatus II.
    Bai G; Armenante PM; Plank RV; Gentzler M; Ford K; Harmon P
    J Pharm Sci; 2007 Sep; 96(9):2327-49. PubMed ID: 17573698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo bioequivalence of commercial prednisone tablets.
    Francisco GE; Honigberg IL; Stewart JT; Kotzan JA; Brown WJ; Schary WL; Pelsor FR; Shah VP
    Biopharm Drug Dispos; 1984; 5(4):335-44. PubMed ID: 6525441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vessel geometric irregularity on dissolution test results.
    Gao Z; Ahadi S; Moore TW; Doub WH; Westenberger BJ; Buhse LF
    J Pharm Sci; 2011 Mar; 100(3):1093-101. PubMed ID: 20803604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.